ID   NCI-H358a
SY   H358a
DR   Wikidata; Q95993568
RX   PubMed=8089864;
RX   PubMed=8280799;
CC   Sequence variation: Heterozygous for KRAS p.Gly12Cys (c.34G>T) (ClinVar=VCV000012578) (from parent cell line).
CC   Sequence variation: Homozygous for TP53 deletion (from parent cell line).
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_1559 ! NCI-H358
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-07-20; Version: 4
RX   PubMed=8089864; DOI=10.1093/jnci/86.19.1458;
RA   Fujiwara T., Cai D.W., Georges R.N., Mukhopadhyay T., Grimm E.A.,
RA   Roth J.A.;
RT   "Therapeutic effect of a retroviral wild-type p53 expression vector in
RT   an orthotopic lung cancer model.";
RL   J. Natl. Cancer Inst. 86:1458-1462(1994).
RX   PubMed=8280799; DOI=10.1089/hum.1993.4.5-617;
RA   Cai D.W., Mukhopadhyay T., Liu Y., Fujiwara T., Roth J.A.;
RT   "Stable expression of the wild-type p53 gene in human lung cancer
RT   cells after retrovirus-mediated gene transfer.";
RL   Hum. Gene Ther. 4:617-624(1993).